These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11972860)
1. Suppression of experimental lupus nephritis by aberrant expression of the soluble E-selectin gene. Takahashi S; Araki K; Araki M; Ito MR; Nakatani K; Fujii H; Izui S; Vassalli P; Nose M Pathol Int; 2002 Mar; 52(3):175-80. PubMed ID: 11972860 [TBL] [Abstract][Full Text] [Related]
2. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Nakatani K; Fujii H; Hasegawa H; Terada M; Arita N; Ito MR; Ono M; Takahashi S; Saiga K; Yoshimoto S; Iwano M; Shiiki H; Saito Y; Nose M Kidney Int; 2004 Apr; 65(4):1290-300. PubMed ID: 15086468 [TBL] [Abstract][Full Text] [Related]
3. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Takahashi S; Itoh J; Nose M; Ono M; Yamamoto T; Kyogoku M Mol Immunol; 1993 Feb; 30(2):177-82. PubMed ID: 8429833 [TBL] [Abstract][Full Text] [Related]
4. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Itoh J; Nose M; Takahashi S; Ono M; Terasaki S; Kondoh E; Kyogoku M Am J Pathol; 1993 Nov; 143(5):1436-43. PubMed ID: 8238259 [TBL] [Abstract][Full Text] [Related]
5. Association between E-selectin expression and histopathological modification of glomerular lesions by non-nephritogenic IgM antibodies in experimental lupus nephritis. Nakatani K; Asai O; Sakan H; Yoshimoto S; Terada M; Nose M; Iwano M; Konishi N Mod Rheumatol; 2014 Sep; 24(5):808-15. PubMed ID: 24372297 [TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice. Nakatani K; Yoshimoto S; Asai O; Sakan H; Terada M; Saito Y; Nose M; Iwano M; Konishi N Immun Inflamm Dis; 2013 Oct; 1(1):37-46. PubMed ID: 25400916 [TBL] [Abstract][Full Text] [Related]
8. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models. Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215 [TBL] [Abstract][Full Text] [Related]
9. Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects. Itoh J; Takahashi S; Ono M; Yamamoto T; Nose M; Kyogoku M Tohoku J Exp Med; 1994 May; 173(1):65-74. PubMed ID: 7809912 [TBL] [Abstract][Full Text] [Related]
10. Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies. Ito MR; Terasaki S; Kondo E; Shiwaku H; Fukuoka Y; Nose M Clin Exp Immunol; 2000 Feb; 119(2):340-5. PubMed ID: 10632673 [TBL] [Abstract][Full Text] [Related]
11. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. Sekine H; Watanabe H; Gilkeson GS J Immunol; 2004 Mar; 172(6):3913-21. PubMed ID: 15004199 [TBL] [Abstract][Full Text] [Related]
12. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/ Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505 [TBL] [Abstract][Full Text] [Related]
13. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. Maeda T; Nomoto K J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559 [TBL] [Abstract][Full Text] [Related]
15. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. Lenda DM; Stanley ER; Kelley VR J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612 [TBL] [Abstract][Full Text] [Related]
16. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). Shimizu S; Sugiyama N; Masutani K; Sadanaga A; Miyazaki Y; Inoue Y; Akahoshi M; Katafuchi R; Hirakata H; Harada M; Hamano S; Nakashima H; Yoshida H J Immunol; 2005 Dec; 175(11):7185-92. PubMed ID: 16301622 [TBL] [Abstract][Full Text] [Related]
17. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. Takahashi S; Nose M; Sasaki J; Yamamoto T; Kyogoku M J Immunol; 1991 Jul; 147(2):515-9. PubMed ID: 2071894 [TBL] [Abstract][Full Text] [Related]
18. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Vlahakos DV; Foster MH; Adams S; Katz M; Ucci AA; Barrett KJ; Datta SK; Madaio MP Kidney Int; 1992 Jun; 41(6):1690-700. PubMed ID: 1501424 [TBL] [Abstract][Full Text] [Related]
19. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. James WG; Bullard DC; Hickey MJ J Immunol; 2003 Jan; 170(1):520-7. PubMed ID: 12496439 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of osteopontin expression in renal tubuli is independent of a histopathological type of glomerular lesions in mouse lupus nephritis. Sasaki Y; Yamamoto Y; Miyazaki T; Ito MR; Nose M; Watanabe M Pathol Int; 2006 Mar; 56(3):135-43. PubMed ID: 16497246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]